Journal Of Clinical And Experimental Hematopathology Indexing, Publication Fee / Time (2024)


journal

Aim and Scope

The Journal Of Clinical And Experimental Hematopathology is a research journal that publishes research in the field of lymphoma, leukemia, macrophage, dendritic cell, hematology, hematopathology. This journal is published by the The Japanese Society for Lymphoreticular Tissue Research. The ISSN of this journal is .

Also, please check the following important details about journal of clinical and experimental hematopathology: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

The ISSN (International Standard Serial Number) is an 8-digit code used to uniquely identify journals. ISSN numbers are assigned by a network of ISSN National Centres, usually located at national libraries and coordinated by the ISSN International Centre based in Paris. The International Centre is an intergovernmental organization created in 1974 through an agreement between UNESCO and the French government.

Important Metrics

Journal Title: Journal of Clinical and Experimental Hematopathology
Publisher: The Japanese Society for Lymphoreticular Tissue Research
P-ISSN:
E-ISSN: 1880-9952
Language: English
Country of Publisher: Japan
APC: Yes
Processing Time (Weeks): 11
Review Process: Peer review
Subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

Indexing

The journal of clinical and experimental hematopathology is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Note: ESCI journals donot come with an impact factor. However, ESCI journals are evaluated every year and those who qualified are transferred to SCIE.


Journal Of Clinical And Experimental Hematopathology Impact Factor 2024

The latest impact factor of journal of clinical and experimental hematopathology is 0.9 which is recently updated in June, 2024.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


Publication fee

According to journal website, the publication fee of journal of clinical and experimental hematopathology is around 150 USD; 15000 JPY.

The journal of clinical and experimental hematopathology has also Journal waiver policy (for developing countries, authors etc).

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.


Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the journal of clinical and experimental hematopathology publishes research articles in 11 weeks on an average.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Journal Of Clinical And Experimental Hematopathology?

If your research is related to lymphoma, leukemia, macrophage, dendritic cell, hematology, hematopathology, then visit the official website of journal of clinical and experimental hematopathology and send your manuscript.

Tips for publishing in Journal Of Clinical And Experimental Hematopathology:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

  • The impact factor of journal of clinical and experimental hematopathology is 0.9.
  • The journal of clinical and experimental hematopathology is a reputed research journal.
  • It is published by The Japanese Society for Lymphoreticular Tissue Research.
  • The journal is indexed in UGC CARE, ESCI, DOAJ, PubMed.
  • It is an open access journal.
  • The publication time (Average number of weeks between article submission and publication) of the journal is 11 weeks.
  • The Publication fee (APC) of journal of clinical and experimental hematopathology 150 USD; 15000 JPY.

Sources: https://www.jsltr.org/eng/AIMS%20AND%20SCOPE.html







SIMILIAR JOURNALS


CYTOTHERAPY

ISSN: 1465-3249
Publisher: ELSEVIER SCI LTD

STEM CELLS

ISSN: 1066-5099
Publisher: OXFORD UNIV PRESS

JOURNAL OF LEUKOCYTE BIOLOGY

ISSN: 0741-5400
Publisher: OXFORD UNIV PRESS

PLATELETS

ISSN: 0953-7104
Publisher: TAYLOR & FRANCIS INC

STEM CELLS AND DEVELOPMENT

ISSN: 1547-3287
Publisher: MARY ANN LIEBERT, INC

CELL REGENERATION

ISSN:
Publisher: SPRINGERNATURE

CELL STEM CELL

ISSN: 1934-5909
Publisher: CELL PRESS

CELLULAR AND MOLECULAR BIOENGINEERING

ISSN: 1865-5025
Publisher: SPRINGER

CURRENT STEM CELL RESEARCH & THERAPY

ISSN: 1574-888X
Publisher: BENTHAM SCIENCE PUBL LTD

INTERNATIONAL JOURNAL OF STEM CELLS

ISSN: 2005-3606
Publisher: KOREAN SOC STEM CELL RESEARCH

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.